Table 6.
eGFR at Randomization and After 6‐Mo Follow‐up by Tertile for AAC Volume in the RDN and Control Groups
| RDN Group | Control Group | Mean Baseline‐Adjusted Difference (95% CI) Between the 2 Groups at 6 Moa | P Value | |||||
|---|---|---|---|---|---|---|---|---|
| Randomization (Mean±SD) | 6 Mo (Mean±SD) | Mean Baseline‐Adjusted Difference (95% CI) | Randomization (Mean±SD) | 6 Mo (Mean±SD) | Mean Baseline‐Adjusted Difference (95% CI) | |||
| Tertile 1 | ||||||||
| eGFR, mL/min | (n=12) | (n=13) | (n=17) | (n=17) | ||||
| 99.1±31.9 | 100.0±28.5 | 2.5 (−3.8 to 8.8) | 97.6±22.4 | 89.6±20.9 | −8.0 (−13.4 to −2.7) | 10.5 (2.2–18.8) | 0.0148 | |
| Tertiles 2 and 3 | ||||||||
| eGFR, mL/min | (n=29) | (n=27) | (n=31) | (n=31) | ||||
| 86.1±21.3 | 76.8±21.9 | −7.5 (−12.5 to −2.6) | 85.5±24.3 | 81.7±23.5 | −3.7 (−8.3 to 0.9) | −3.8 (−10.6 to 3.0) | 0.2640 | |
AAC indicates abdominal aortic calcifications; CI, confidence interval; eGFR, estimated glomerular filtration rate; RDN, renal denervation.
a
RDN group vs control group.